Literature DB >> 16443895

The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men.

Peter T Katzmarzyk1, Ian Janssen, Robert Ross, Timothy S Church, Steven N Blair.   

Abstract

OBJECTIVE: The purpose of this study was to compare the predictive ability of the National Cholesterol Education Panel (NCEP), revised NCEP (NCEP-R), and International Diabetes Federation (IDF) metabolic syndrome criteria for mortality risk, and to examine the effects of waist circumference on mortality within the context of these criteria. RESEARCH DESIGN AND METHODS: The sample included 20,789 white, non-Hispanic men 20-83 years of age from the Aerobics Center Longitudinal Study. The main outcome measures were all-cause and cardiovascular disease (CVD) mortality over 11.4 years of follow-up.
RESULTS: The proportions of men with the metabolic syndrome were 19.7, 27, and 30% at baseline, respectively, according to NCEP, NCEP-R, and IDF criteria. A total of 632 deaths (213 CVD) occurred. The relative risks (RRs) and 95% CIs of all-cause mortality were 1.36 (1.14-1.62), 1.31 (1.11-1.54), and 1.26 (1.07-1.49) for the NCEP, NCEP-R, and IDF definitions, respectively. The corresponding RRs for CVD mortality were 1.79 (1.35-2.37), 1.67 (1.27-2.19), and 1.67 (1.27-2.20). Additionally, there was a significant trend for a higher risk of CVD mortality across waist circumference categories (<94, 94-102, and >102 cm) among men with at least two additional metabolic syndrome risk factors (P = 0.01).
CONCLUSIONS: The prediction of mortality with IDF and NCEP metabolic syndrome criteria was comparable in men. Waist circumference is a valuable component of metabolic syndrome; however, the IDF requirement of an elevated waist circumference warrants caution given that a large proportion of men with normal waist circumference have multiple risk factors and an increased risk of mortality.

Entities:  

Mesh:

Year:  2006        PMID: 16443895     DOI: 10.2337/diacare.29.02.06.dc05-1636

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  61 in total

1.  Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities.

Authors:  Rachel P Wildman; Aileen P McGinn; Juan Lin; Dan Wang; Paul Muntner; Hillel W Cohen; Kristi Reynolds; Vivian Fonseca; MaryFran R Sowers
Journal:  Obesity (Silver Spring)       Date:  2010-08-19       Impact factor: 5.002

Review 2.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

3.  Body mass index and the prevalence, severity, and risk of coronary artery disease: an international multicentre study of 13,874 patients.

Authors:  Troy M Labounty; Millie J Gomez; Stephan Achenbach; Mouaz Al-Mallah; Daniel S Berman; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Victor Cheng; Kavitha M Chinnaiyan; Benjamin Chow; Ricardo Cury; Augustin Delago; Allison Dunning; Gudrun Feuchtner; Martin Hadamitzky; Jorg Hausleiter; Philipp Kaufmann; Yong-Jin Kim; Jonathon Leipsic; Fay Y Lin; Erica Maffei; Gilbert Raff; Leslee J Shaw; Todd C Villines; James K Min
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-08-24       Impact factor: 6.875

4.  Progression from metabolically benign to at-risk obesity in perimenopausal women: a longitudinal analysis of study of women across the nation (SWAN).

Authors:  Unab I Khan; Dan Wang; Carrie A Karvonen-Gutierrez; Naila Khalil; Kelly R Ylitalo; Nanette Santoro
Journal:  J Clin Endocrinol Metab       Date:  2014-05-20       Impact factor: 5.958

5.  Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.

Authors:  Todd M Brown; Jenifer H Voeks; Vera Bittner; Monika M Safford
Journal:  Am Heart J       Date:  2010-03       Impact factor: 4.749

6.  Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009.

Authors:  T Du; X Sun; R Huo; X Yu
Journal:  Int J Obes (Lond)       Date:  2013-09-19       Impact factor: 5.095

7.  Effects of aquajogging in obese adults: a pilot study.

Authors:  Eveline J M Wouters; Annemieke M A Van Nunen; Rinie Geenen; Ronette L Kolotkin; Ad J J M Vingerhoets
Journal:  J Obes       Date:  2009-08-20

8.  Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study.

Authors:  Alexandra D Ogorodnikova; Unab I Khan; Aileen P McGinn; Irfan Zeb; Matthew J Budoff; S M Harman; Virginia M Miller; Eliot A Brinton; JoAnn E Manson; Howard N Hodis; George R Merriam; Marcelle I Cedars; Hugh S Taylor; Frederick Naftolin; Rogerio A Lobo; Nanette Santoro; Rachel P Wildman
Journal:  Obesity (Silver Spring)       Date:  2013-05-13       Impact factor: 5.002

9.  BMI, weight stability and mortality among adults without clinical co-morbidities: a 22-year mortality follow-up in the Finnish twin cohort.

Authors:  Maarit Korkeila; Aila Rissanen; Thorkild I A Sørensen; Jaakko Kaprio
Journal:  Obes Facts       Date:  2009-12-04       Impact factor: 3.942

10.  Metabolic syndrome and insulin resistance in subjects with morbid obesity.

Authors:  Valentina Soverini; Simona Moscatiello; Nicola Villanova; Elisabetta Ragni; Silvia Di Domizio; Giulio Marchesini
Journal:  Obes Surg       Date:  2009-10-20       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.